XRS [TAL Education] 424B4: (Original Filing)
[]
XRS [TAL Education] 424B4: (Original Filing)
[No.333-169650 TAL Education 12,000,000 American Depositary Shares Representing 24,000,000 ClassAmmon Shares This is an initial public offering of American depositary shares, orSs, of TAL Education. We are offering 12,000,000ADSs. EachS represents two ClassAmmon shares, par value $0.001 per share. See Risk Factors beginning on page12 to readout risks you shouldnsider before buying theSs.]
XRS [TAL Education] 424B4: No.333-169650 TAL Education 12,000,000 American Depositary Shares Representing
[No.333-169650 TAL Education 12,000,000 American Depositary Shares Representing 24,000,000 ClassAmmon Shares This is an initial public offering of American depositary shares, orSs, of TAL Education. We are offering 12,000,000ADSs. EachS represents two ClassAmmon shares, par value $0.001 per share. See Risk Factors beginning on page12 to readout risks you shouldnsider before buying theSs.]
JKS [JinkoSolar] 6-K: (Original Filing)
[JinkoSolar Holding Co., Ltd. S ONGGEN HANG / Longgen Zhang]
JKS [JinkoSolar] 6-K: JinkoSolar Holding Co., Ltd. S ONGGEN HANG /
[JinkoSolar Holding Co., Ltd. S ONGGEN HANG / Longgen Zhang]
CO [China Cord Blood] F-3/A: (Original Filing)
[EXPLANATORY NOTE they contain different outside and inside front covers and back covers; 1 5 they contain different Use of Proceeds sections on page ] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our reports dated July 15, 2010 with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting incorporated by reference herein and in the registration statement on Form S-4 (File No. 333-155579) and to] [John Reynolds October 20, 2010 Page 2 General 1. Please comply with the comments that were issued on the company’s Form 20-F for the year ended December 31, 2009, in the staff’s letter dated August 19, 2010. Please amend the registration statement in response to these comments, if appropriate. COMPANY RESPONSE: The Company has filed an amended Form 20-F for]
CO [China Cord Blood] F-3/A: EXPLANATORY NOTE they contain different
[EXPLANATORY NOTE they contain different outside and inside front covers and back covers; 1 5 they contain different Use of Proceeds sections on page ] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: We consent to the use of our reports dated July 15, 2010 with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting incorporated by reference herein and in the registration statement on Form S-4 (File No. 333-155579) and to] [John Reynolds October 20, 2010 Page 2 General 1. Please comply with the comments that were issued on the company’s Form 20-F for the year ended December 31, 2009, in the staff’s letter dated August 19, 2010. Please amend the registration statement in response to these comments, if appropriate. COMPANY RESPONSE: The Company has filed an amended Form 20-F for]
